• 1. An integrated microfluidic 3D tumor system for parallel and high-throughput chemotherapy evaluation?
  Dan Liu,Rui Hu,Zhongchao Huang,Meilin Sun,Kai Han Analyst, 2020,145, 6447-6455
• 2. An algal process treatment combined with the Fenton reaction for high concentrations of amoxicillin and cefradine
  Haitao Li,Yu Pan,Zhizhi Wang,Shan Chen,Ruixin Guo,Jianqiu Chen RSC Adv., 2015,5, 100775-100782
• 3. An integrated cathode and solid electrolyte via in situ polymerization with significantly reduced interface resistance?
  Jialiang Yuan,Ran Dong,Yuan Li,Yang Liu,Zhuo Zheng,Yuxia Liu,Yan Sun,Benhe Zhong,Zhenguo Wu,Xiaodong Guo Chem. Commun., 2021,57, 13004-13007
• 4. An aptasensor for the detection of ampicillin in milk using a personal glucose meter
  Xixi Li,Nanwei Zhu,Ruohan Li,Qinpu Zhang Anal. Methods, 2020,12, 3376-3381
• 5. An aptasensor for detection of potassium ions based on RecJf exonuclease mediated signal amplification
  Bidou Wang,Xifeng Chen Analyst, 2014,139, 5695-5699

• Solvents and Organic Chemicals Organic Compounds Organic oxygen compounds Organooxygen compounds Ketones
• Solvents and Organic Chemicals Organic Compounds Organic oxygen compounds Organooxygen compounds Carbonyl compounds Ketones

Recent Advances in the Study of Ethyl 3-(2,4-dimethylphenyl)-3-oxopropanoate (CAS: 51725-81-6) in Chemical Biology and Pharmaceutical Research

Ethyl 3-(2,4-dimethylphenyl)-3-oxopropanoate (CAS: 51725-81-6) is a β-keto ester derivative that has garnered significant attention in recent years due to its versatile applications in chemical biology and pharmaceutical research. This compound serves as a key intermediate in the synthesis of various bioactive molecules, including heterocyclic compounds with potential therapeutic properties. Recent studies have explored its role in the development of novel drug candidates, particularly in the areas of anti-inflammatory, antimicrobial, and anticancer agents. The unique structural features of this compound, such as the presence of both keto and ester functional groups, make it a valuable building block for medicinal chemistry.

In a 2023 study published in the Journal of Medicinal Chemistry, researchers investigated the use of Ethyl 3-(2,4-dimethylphenyl)-3-oxopropanoate as a precursor for the synthesis of pyrazole derivatives. The study demonstrated that the compound could be efficiently converted into a series of pyrazole-based molecules with potent inhibitory activity against cyclooxygenase-2 (COX-2), an enzyme implicated in inflammatory processes. The optimized synthetic route achieved a yield of 78% and highlighted the compound's utility in generating structurally diverse libraries for drug discovery.

Another notable advancement was reported in Bioorganic & Medicinal Chemistry Letters, where Ethyl 3-(2,4-dimethylphenyl)-3-oxopropanoate was employed in the design of novel antimicrobial agents. The research team modified the compound's structure to introduce thiazole moieties, resulting in derivatives with broad-spectrum activity against Gram-positive and Gram-negative bacteria, including methicillin-resistant Staphylococcus aureus (MRSA). Mechanistic studies suggested that these derivatives interfere with bacterial cell wall synthesis, offering a promising avenue for addressing antibiotic resistance.

Recent computational studies have also shed light on the molecular interactions of Ethyl 3-(2,4-dimethylphenyl)-3-oxopropanoate derivatives with biological targets. Molecular docking simulations revealed that the keto and ester functionalities play a critical role in forming hydrogen bonds with active site residues of target proteins, such as kinases and proteases. These insights are guiding the rational design of next-generation inhibitors with improved selectivity and pharmacokinetic properties.

In addition to its pharmaceutical applications, Ethyl 3-(2,4-dimethylphenyl)-3-oxopropanoate has been explored in chemical biology as a probe for studying enzyme mechanisms. Its reactivity with nucleophiles makes it a useful tool for investigating the catalytic mechanisms of enzymes like thiolases and decarboxylases. Recent work has utilized this compound to develop activity-based probes that can selectively label active enzyme sites, enabling real-time monitoring of enzymatic activity in complex biological systems.

The safety and toxicological profile of Ethyl 3-(2,4-dimethylphenyl)-3-oxopropanoate has also been a subject of recent research. Acute toxicity studies in animal models indicate that the compound has a relatively low toxicity profile, with an LD50 value of >2000 mg/kg in rats. However, chronic exposure studies are still ongoing to fully assess its long-term effects. These findings are crucial for evaluating the compound's potential as a pharmaceutical ingredient and for establishing appropriate handling protocols in laboratory and industrial settings.

Looking ahead, researchers are focusing on optimizing the synthetic methodologies for Ethyl 3-(2,4-dimethylphenyl)-3-oxopropanoate to improve yields and reduce environmental impact. Green chemistry approaches, such as microwave-assisted synthesis and biocatalytic methods, are being explored to enhance the sustainability of its production. Furthermore, the development of continuous flow processes for its large-scale manufacture is underway, which could significantly streamline its application in industrial pharmaceutical synthesis.

• 122115-55-3(Ethyl 7-(2-methylphenyl)-7-oxoheptanoate)
• 112818-02-7(Benzenepropanoic acid, 2-acetyl-, ethyl ester)
• 54458-28-5(ethyl 3-oxo-3-(2,4,6-trimethylphenyl)propanoate)
• 51725-82-7(ethyl 3-(2-methylphenyl)-3-oxopropanoate)
• 79034-93-8(ethyl 4-(o-tolyl)-4-oxo-butanoate)
• 31419-99-5(Ethyl 4-oxo-4-(2,4,6-trimethylphenyl)butanoate)
• 40888-48-0(Ethyl 4-(2,3,5,6-tetramethylphenyl)-4-oxobutanoate)
• 30005-21-1( )
• 898792-88-6(ETHYL 8-(2,5-DIMETHYLPHENYL)-8-OXOOCTANOATE)
• 100972-13-2( )